When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Sickle Cell Disease - Treatment | NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/treatment

    View fact sheet. Crizanlizumab-tmca is approved for adults and children ages 16 years and older who have sickle cell disease. The medicine is given through an intravenous (IV) line in the vein once a month. The medicine helps prevent blood cells from sticking to blood vessel walls and blocking blood flow.

  3. Sickle Cell Disease - What Is Sickle Cell Disease? - NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease

    Sickle cell disease — also called sickle cell anemia — is a group of inherited disorders that affect hemoglobin , the major protein that carries oxygen in red blood cells. Normally, red blood cells are disc-shaped and flexible so they can move easily through the blood vessels. In sickle cell disease, red blood cells are misshaped, typically ...

  4. Evidence-Based Management of Sickle Cell Disease: Expert Panel...

    www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease

    Evidence-Based Management of Sickle Cell Disease: Expert Panel Report, 2014. Published Sep 2014. Download PDF 3 MB. These guidelines were developed by an expert panel composed of health care professionals with expertise in family medicine, general internal medicine, adult and pediatric hematology, psychiatry, transfusion medicine, obstetrics ...

  5. Opioid crisis adds to pain of sickle cell patients - NHLBI, NIH

    www.nhlbi.nih.gov/news/2017/opioid-crisis-adds-pain-sickle-cell-patients

    Opioid crisis adds to pain of sickle cell patients. September 15, 2017. As the country struggles with the devastating opioid crisis, researchers say it could have dire consequences for one population with few pain-relieving alternatives: people living with sickle cell disease. The increasingly tight restrictions on opioid access, they say, is ...

  6. Hydroxyurea Use for Sickle Cell Disease Fact Sheet

    www.nhlbi.nih.gov/resources/hydroxyurea-use-sickle-cell-disease-fact-sheet

    Overview. Hydroxyurea is an oral medicine that can help reduce sickle cell disease complications. This fact sheet will provide the facts about hydroxyurea, potential benefits and risks, and questions to ask your healthcare provider. Print Length:

  7. Evidence-Based Management of Sickle Cell Disease - NHLBI, NIH

    www.nhlbi.nih.gov/sites/default/files/media/docs/Evd-Bsd_SickleCellDis_Rep2014.pdf

    Chapter 5 Hydroxyurea Therapy in the Management of Sickle Cell Disease . 31. Chapter 6 Blood Transfusion in the Management of Sickle Cell Disease . 35. Chapter 6 Blood Transfusion in the Management of Sickle Cell Disease . 35. Chapter 6 Blood Transfusion in the Management of Sickle Cell Disease . 35. Indications for Transfusion. 35

  8. Sickle Cell Disease - Causes and Risk Factors - NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/causes

    However, in sickle cell disease, the body has trouble keeping up with the rate that the cells are being destroyed. This can lead to a low number of red blood cells, called anemia. The resulting anemia can cause a person to be easily tired with less energy. Normal red cells and sickled red cells.

  9. Sickle Cell Disease - Symptoms - NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/symptoms

    Serious pain linked with sickle cell disease often requires treatment in a clinic or hospital. Fatigue (extreme tiredness), shortness of breath, dizziness, and irregular heartbeat. These are symptoms of serious anemia. Life-threatening anemia can be caused by conditions such as a splenic sequestration crisis crisis or an aplastic crisis .

  10. Pregnancy, Reproduction, and Sickle Cell Disease - NHLBI, NIH

    www.nhlbi.nih.gov/health/sickle-cell-disease/pregnancy

    Pregnancy, Reproduction, and Sickle Cell Disease. Sickle cell disease can affect sexual organs and other parts of the body in ways that affect quality of life and reproduction. Pregnancy puts extra stress on a woman’s body, raising the risk of sickle cell complications. Having sickle cell disease also raises the risk of problems with the ...

  11. Sickle Cell Disease Research - NHLBI, NIH

    www.nhlbi.nih.gov/research/sickle-cell-disease

    For example, one study is comparing treatment of severe sickle cell disease with BMTs using cells from either an unrelated immune-matched donor or from a mismatched donor. Find more NHLBI-funded studies on sickle cell disease treatment at NIH RePORTER. Information on NHLBI-supported sickle cell disease treatment clinical trials is also available.